Primary vaccination with the LiESP/QA-21 vaccine (CaniLeish) produces a cell-mediated immune response which is still present 1 year later (Q56767146)

6

object named as

Sylvie Gueguen

0 references

author name string

Ioannis Vouldoukis

2

0 references

Paul Schreiber

3

0 references

Virginie Martin

4

0 references

David McGahie

5

0 references

Anne-Marie Cuisinier

Veterinary Immunology and Immunopathology

7

0 references

language of work or name

English

0 references

publication date

15 April 2014

0 references

published in

0 references

volume

158

0 references

issue

3-4

0 references

page(s)

199-207

0 references

cites work

T helper (h)1/Th2 and Leishmania: paradox rather than paradigm

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2014.01.011

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2014.01.011

Canine leishmaniosis - new concepts and insights on an expanding zoonosis: part one.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2014.01.011

Immunology of canine leishmaniasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2014.01.011

Identification of novel Leishmania donovani antigens that help define correlates of vaccine-mediated protection in visceral leishmaniasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2014.01.011

Reactive oxygen and reactive nitrogen intermediates in innate and specific immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2014.01.011

Effective humoral and cellular immunoprotective responses in Li ESAp-MDP vaccinated protected dogs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2014.01.011

Immunogenicity of HSP-70, KMP-11 and PFR-2 leishmanial antigens in the experimental model of canine visceral leishmaniasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2014.01.011

Cytokine profiles in canine visceral leishmaniasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2014.01.011

Immunoglobulin G subclass distribution in canine leishmaniosis: a review and analysis of pitfalls in interpretation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2014.01.011

Immune system development in the dog and cat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2014.01.011

The current status of zoonotic leishmaniases and approaches to disease control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2014.01.011

Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2014.01.011

Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2014.01.011

Lymphocytes of dogs immunised with purified excreted-secreted antigens of Leishmania infantum co-incubated with Leishmania infected macrophages produce IFN gamma resulting in nitric oxide-mediated amastigote apoptosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2014.01.011

The northward spread of leishmaniasis in Italy: evidence from retrospective and ongoing studies on the canine reservoir and phlebotomine vectors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2014.01.011

Does the Leishmania major paradigm of pathogenesis and protection hold for New World cutaneous leishmaniases or the visceral disease?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2014.01.011

The immune response and PBMC subsets in canine visceral leishmaniasis before, and after, chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2014.01.011

Canine leishmaniasis: epidemiological risk and the experimental model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2014.01.011

Use of a LiESP/QA-21 vaccine (CaniLeish) stimulates an appropriate Th1-dominated cell-mediated immune response in dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2014.01.011

Cytokines that regulate macrophage production of nitrogen oxides and expression of antileishmanial activities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2014.01.011

Exploitation of parasite-derived antigen in therapeutic success against canine visceral leishmaniosis. Veterinary Group of Lupino

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2014.01.011

Alternatively activated macrophages during parasite infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2014.01.011

The prevention of canine leishmaniasis and its impact on public health

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2014.01.011

Reduced nitric oxide synthase 2 (NOS2) promoter activity in the Syrian hamster renders the animal functionally deficient in NOS2 activity and unable to control an intracellular pathogen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2014.01.011

Immunity to Leishmania and the rational search for vaccines against canine leishmaniasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2014.01.011

Leishmania-infected MHC class IIhigh dendritic cells polarize CD4+ T cells toward a nonprotective T-bet+ IFN-γ+ IL-10+ phenotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2014.01.011

Cytokine expression during the outcome of canine experimental infection by Leishmania infantum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2014.01.011

Prevalence of Leishmania infantum infection in dogs living in an area of canine leishmaniasis endemicity using PCR on several tissues and serology.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2014.01.011

Directions for the diagnosis, clinical staging, treatment and prevention of canine leishmaniosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2014.01.011

Splenic immune responses during canine visceral leishmaniasis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2014.01.011

The killing of Leishmania major by human macrophages is mediated by nitric oxide induced after ligation of the Fc epsilon RII/CD23 surface antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2014.01.011

Interleukin-10 and interleukin-4 inhibit intracellular killing of Leishmania infantum and Leishmania major by human macrophages by decreasing nitric oxide generation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2014.01.011

Canine visceral leishmaniasis: comparison of in vitro leishmanicidal activity of marbofloxacin, meglumine antimoniate and sodium stibogluconate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2014.01.011

L-arginine metabolism and its impact on host immunity against Leishmania infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2014.01.011

High iNOS expression in macrophages in canine leishmaniasis is associated with low intracellular parasite burden

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2014.01.011